ClinicalTrials.Veeva

Menu

Prevalence of Keratoconus in Inflammatory Bowel Diseases (OSCAR)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Keratoconus
Inflammatory Bowel Diseases

Treatments

Device: Opthalmologic measure with DM OPD scan III (Nidek)

Study type

Interventional

Funder types

Other

Identifiers

NCT02861339
2013-A01680-45

Details and patient eligibility

About

A retrospective study has shown the association between the inflammatory bowel diseases (IBD) and the presence of a keratoconus. This new study will measure the prevalence of keratoconus and follow its activity in patients affected by IBD and followed up in hepatology-gastroenterology department at Nancy Hospital. The prevalence of keratoconus will be compared to known data of literature about general population.

The secondary purpose is to search for a relationship between the presence of a keratoconus and activity criteria of IBD.

Perspectives are a systematic screening for keratoconus in patients affected by IBD with the amelioration of the ophthalmologic care of IBD patients and confirmation of the recent hypothesis of inflammatory origin of keratoconus.

Enrollment

201 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent
  • Affiliation to social security plan
  • Diagnosis of IBD since more than 3 years, under treatment or not

Exclusion criteria

  • Protected person
  • Pregnant or breastfeeding women
  • Person in life-and-death emergency
  • Person deprived of liberty
  • Refusal to remove contact lenses, where necessary

Trial design

201 participants in 1 patient group

Keratoconus and IBD
Experimental group
Description:
Opthalmologic measure with DM OPD scan III (Nidek)
Treatment:
Device: Opthalmologic measure with DM OPD scan III (Nidek)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems